SA
Sana Biotech
SANA·NASDAQSeattle WAFounded 2018250 employees
Small CapbiotechPublicOncologyGenetic Medicine
Platform: In Vivo Cell Eng
Market Cap
$0.5B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (SANA)
Loading SANA stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Poladerotide | SAN-7928 | Phase 1/2 | 1 | SMN2 | Cholangiocarcinoma | ||
| SAN-4302 | SAN-4302 | Phase 1 | 1 | WRN | Alzheimer'sPBC |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)